Background Almost 30% of children in Southern Africa are HIV exposed but uninfected
(HEU) and experience exposures that could increase vulnerability to infectious diseases …

Background: Growth failure is common among HIV-infected infants, but there are limited
data on the effects of HIV exposure or timing of HIV acquisition on growth. Methods …

Simple Summary Although the use of antiretroviral treatment (ART) is effective in reducing
the risk of HIV transmission to the foetus, there are concerns of possible adverse effects of in …

HIV‐exposed and HIV‐uninfected (HEU) infants may be at increased risk of poor health and
growth outcomes. We characterized infant growth trajectories in a cohort of HEU infants to …

Background Commencing lifelong antiretroviral therapy (ART) immediately following HIV
diagnosis (Option B+), has greatly improved maternal-infant health. Thus, large and …

With expanded HIV treatment and prevention programmes, most infants born to HIV‐positive
women are uninfected, but the patterns and determinants of their growth are not well …

Increased morbidity and fetal growth restriction are reported in uninfected children born to
human immunodeficiency virus type 1 (HIV-1)–infected women treated with antiretroviral …

Background: HIV-exposed but uninfected (HEU) infants are at increased risk of impaired
early linear growth and cognitive development. We examined associations between …

Background Long-term growth in HIV-infected infants treated early in resource-limited
settings is poorly documented. Incidence of growth retardation, instantaneous risk of death …

Introduction Mother-to-child-transmission (MTCT) of human immunodeficiency virus (HIV)
can occur in pregnancy/in utero (IU), during childbirth/intrapartum (IP), or postpartum (PP) …